Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

68 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-23

Study Completion Date

2017-06-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Interstitial lung disease (ILD) is a restrictive lung disease characterized by impaired lung function, exercise limitation and skeletal muscle dysfunction. There is limited data on skeletal muscle function in ILD, most of which are focused on the lower limb muscles. The aim of this study were to evaluated the change of pectoralis muscle strength and relationship of pulmonary function with pectoralis muscle strength.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Upper and Lower Limb Maximal Exercise Capacities and Muscle Oxygenation in Patients With ILD

NCT06141603

Interstitial Lung Disease

RECRUITING

Muscles Oxygenation During Exercise in Fibrosing Interstitial Lung Diseases

NCT05855447

Lung Diseases, Interstitial Exercise, Compulsive Oxygen Deficiency

COMPLETED

Effects of Home-based Inspiratory Muscle Training in Patients With IPF

NCT05353556

Idiopathic Pulmonary Fibrosis IPF

COMPLETED NA

The Effect of Respiratory Muscle Strength and Functional Capacity on Posture and Balance

NCT05005533

Chronic Obstructive Pulmonary Disease

UNKNOWN

Functional Inspiratory Training in Bronchiectasis

NCT07188675

Bronchiectasis Functional Inspiratory Muscle Training

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study consisted of intervention and control groups. Thirty one patients with ILD were included in the patient's group and 37 healthy volunteers in the control group. All participants were selected from the geriatric population. Demographic and cardiopulmonary physiotherapy assessment of all participants were performed. Lung function test, maximal inspiratory and expiratory pressure and pectoralis muscle strength were measured in participants of both groups. All measurements were performed once.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Interstitial Lung Disease Idiopathic Pulmonary Fibrosis Sarcoidosis, Pulmonary Geriatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient's group

geriatric patients with interstitial lung disease

Assessment of pulmonary function and pectoralis muscle strength

Intervention Type OTHER

In both groups, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1 / FVC ratio were measured with portable spirometer according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS). Maximal inspiratory (MIP) and expiratory pressure (MEP) were evaluated with mouth pressure device as per ATS/ERS guidelines. Sensation of dyspnea was assessed with Modified medical council research scale. Pectoralis muscle strength were measured isometrically using with digital hand held dynamometer.

Control group

healthy volunteers selected from the geriatric population

Assessment of pulmonary function and pectoralis muscle strength

Intervention Type OTHER

In both groups, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1 / FVC ratio were measured with portable spirometer according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS). Maximal inspiratory (MIP) and expiratory pressure (MEP) were evaluated with mouth pressure device as per ATS/ERS guidelines. Sensation of dyspnea was assessed with Modified medical council research scale. Pectoralis muscle strength were measured isometrically using with digital hand held dynamometer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment of pulmonary function and pectoralis muscle strength

In both groups, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1 / FVC ratio were measured with portable spirometer according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS). Maximal inspiratory (MIP) and expiratory pressure (MEP) were evaluated with mouth pressure device as per ATS/ERS guidelines. Sensation of dyspnea was assessed with Modified medical council research scale. Pectoralis muscle strength were measured isometrically using with digital hand held dynamometer.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with ILD by a multidisciplinary team according to the 2011 ATS/ERS guidelines for ILD
* Aged 65-85

Exclusion Criteria

* Uncontrolled/active cardiovascular, metabolic, systemic or cancerous disease
* Significant orthopedic, neurologic or musculoskeletal comorbidity that limited functional independence
* No being able to cooperate
* Refuse to participate in the current study

Minimum Eligible Age

65 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes